Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: JTT-662;   Drug: Placebo Sponsor:   Akros Pharma Inc. Recruiting

Source: ClinicalTrials.gov - July 10, 2020 Category: Research Source Type: clinical trials